Back to search

Article

ATF4 alleviates doxorubicin-induced cardiomyopathy through H <sub>2</sub> S-mediated antioxidation

2025-09-11

Abstract excerpt

<h4>Background</h4> Doxorubicin (DOX) remains a cornerstone in the treatment of various cancers. However, its clinical utilization is significantly hampered by dose-dependent cardiotoxicity. The generation of reactive oxygen species (ROS) constitutes the central component of the pathogenesis of DOX-induced cardiotoxicity. Activating transcription factor 4 (ATF4) has been demonstrated to exert a cardioprotective e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
657e2a95-e4e7-57ce-89e8-d814fdb69414
DOI
10.1101/2025.09.03.674119
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ATF4 alleviates doxorubicin-induced cardiomyopathy through H <sub>2</sub> S-mediated antioxidationDOI 10.1101/2025.09.03.674119
Select a neighboring publication to make it the new centre.